Crossmark

Progression of FIB-4 index predicts major adverse cardiovascular events in patients with metabolic dysfunction

Crossref DOI link: https://doi.org/10.1016/j.gastrohep.2025.502608

Published Print: 2026-03

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Idalsoaga, Francisco

Cambindo, Verónica

Fuentes-López, Eduardo

Dukes, Eitan

Ibañez, Samuel

Hunfan, Paola

Mollo, Constanza

Gonzalez, Jorge

Ayares, Gustavo

Ramirez-Cadiz, Carolina

Barrera, Francisco

Acevedo, Monica

Kamath, Patrick S.

Sterling, Richard

Arrese, Marco

Díaz, Luis Antonio

Arab, Juan Pablo
Funding

Funding for this research was provided by:

Fondo Nacional de Desarrollo Científico y Tecnológico (1241450)

National Agency for Research and Development
License Information

Text and Data Mining valid from 2026-03-01

Text and Data Mining valid from 2026-03-01

stm-asf valid from 2026-03-01

stm-asf valid from 2026-03-01

stm-asf valid from 2026-03-01

stm-asf valid from 2026-03-01

stm-asf valid from 2026-03-01
More Information

This article is maintained by: Elsevier

Article Title: Progression of FIB-4 index predicts major adverse cardiovascular events in patients with metabolic dysfunction

Journal Title: Gastroenterología y Hepatología

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.gastrohep.2025.502608

Content Type: article

Copyright: © 2025 Elsevier España, S.L.U. All rights are reserved, including those for text and data mining, AI training, and similar technologies.